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CLC channels and transporters are expressed in most tissues and fulfill diverse functions.
There are four human CLC channels, ClC-1, ClC-2, ClC-Ka, and ClC-Kb, and five CLC
transporters, ClC-3 through −7. Some of the CLC channels additionally associate with
accessory subunits. Whereas barttin is mandatory for the functional expression of ClC-K,
GlialCam is a facultative subunit of ClC-2 which modifies gating and thus increases the
functional variability within the CLC family. Isoform-specific ion conduction and gating
properties optimize distinct CLC channels for their cellular tasks. ClC-1 preferentially
conducts at negative voltages, and the resulting inward rectification provides a large
resting chloride conductance without interference with the muscle action potential.
Exclusive opening at voltages negative to the chloride reversal potential allows for
ClC-2 to regulate intracellular chloride concentrations. ClC-Ka and ClC-Kb are equally
suited for inward and outward currents to support transcellular chloride fluxes. Every
human CLC channel gene has been linked to a genetic disease, and studying these
mutations has provided much information about the physiological roles and the molecular
basis of CLC channel function. Mutations in the gene encoding ClC-1 cause myotonia
congenita, a disease characterized by sarcolemmal hyperexcitability and muscle stiffness.
Loss-of-function of ClC-Kb/barttin channels impairs NaCl resorption in the limb of Henle
and causes hyponatriaemia, hypovolemia and hypotension in patients suffering from
Bartter syndrome. Mutations in CLCN2 were found in patients with CNS disorders but
the functional role of this isoform is still not understood. Recent links between ClC-1 and
epilepsy and ClC-Ka and heart failure suggested novel cellular functions of these proteins.
This review aims to survey the knowledge about physiological and pathophysiological
functions of human CLC channels in the light of recent discoveries from biophysical,
physiological, and genetic studies.
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INTRODUCTION
Expression cloning of a chloride channel from Torpedo mar-
morata—now called ClC-0—by Jentsch et al. (1990) established
the CLC family of anion transport proteins (Figure 1A). The
CLC family encompasses nine human CLC proteins, ClC-1
through −7 and the ClC-Ka and -Kb proteins. Single-channel
recordings on ClC-0 revealed unitary conductances of about
10 pS (Miller, 1982), and since this value predicts a transport
rate far above the maximum rates of transporters and pumps
there was little doubt that this protein mediates anion diffusion
through an aqueous conduction pathway. Unitary current ampli-
tudes of ClC-1 and ClC-2 supported this idea (Pusch et al., 1994;
Weinreich and Jentsch, 2001), so that all members of the family
were initially assumed to represent anion channels. It thus came as
a surprise when a bacterial homolog in E. coli was shown to func-
tion as a coupled anion/proton exchanger (Accardi and Miller,
2004). Successive analysis of transport mechanisms of human
CLC isoforms demonstrated that five out of nine human CLCs,
ClC-3 through ClC-7, represent anion-proton exchangers rather
than anion channels (Picollo and Pusch, 2005; Scheel et al., 2005;
Neagoe et al., 2010; Leisle et al., 2011; Guzman et al., 2013). The
CLC family thus combines two functional groups with thermo-
dynamically different transport processes. All experimental data
presented so far support a close structural similarity of the mem-
bers of the CLC family and demonstrate that transport proteins of
similar structure can specialize into ion channels or transporters.
CLC channels and transporters fulfill different physiological
tasks. Whereas CLC exchangers are mainly expressed in intracel-
lular compartments such as endosomes or lysosomes and seem
to contribute to housekeeping regulation of these organelles,
CLC channels are located in the surface membrane of excitable
and epithelial cells and contribute to the regulation of mem-
brane excitability as well as to the transport of electrolytes, water,
and nutrients. In this review, we focus exclusively on the chan-
nel branch of the CLC family, summarizing their function, their
cellular roles and possible involvement in diseases.
MOLECULAR PHYSIOLOGY OF CLC CHANNELS
STRUCTURAL DETERMINANTS OF CLC CHANNEL FUNCTION
So far, no high-resolution three-dimensional structure has been
reported for a CLC channel. However, CLC anion/proton
exchangers have been crystallized from several prokaryotic and
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FIGURE 1 | The CLC family of transport proteins encompasses chloride
channels and chloride/proton exchangers. (A) A phylogram
demonstrates the early separation of the human CLC proteins into one
branch of chloride channels encompassing ClC-1, ClC-2, ClC-Ka, and
ClC-Kb. The chloride/proton antiporters encompass ClC-3 through −7. ClC-K
channels require the subunit barttin while ClC-7 is dependent on the
presence of Ostm1 for normal function. Recently, GlialCAM has been
identified as accessory subunit of ClC-2. (B) A view of the dimer of cmClC
[PDB ID: 3ORG (Feng et al., 2010)] in a ribbon presentation. One subunit is
shown in light gray while the other subunit is shown in color ranging from
the beginning of the B-helix in blue to the carboxy terminus in red. The
upper part of the protein comprises the transmembrane core while the
lower red part contains the carboxy termini with the CBS domains. (C) A
closer view of some of the critical residues coordinating the chloride ions in
ecClC (PDB ID: 1OTS). The magenta colored residues Y445 and S107 are
responsible for the binding of chloride (green sphere) in Scen and are also
proposed to be critical for slow gating of the CLC channels. E148
represents the so-called “gating glutamate” swinging from Scen to Sext and
is thought to be tightly involved in fast protopore gating of CLC channels.
eukaryotic species (Dutzler et al., 2002; Accardi et al., 2006; Lobet
and Dutzler, 2006; Feng et al., 2010; Robertson et al., 2010;
Jayaram et al., 2011; Lim et al., 2012). Since structural properties
of CLC transporters translate well for structure-function investi-
gations performed on CLC channels (Miller, 2003), it is generally
assumed that CLC channels are structurally very similar to CLC
transporters.
All CLC proteins are assembled as dimers, with each subunit
exhibiting 18 transmembrane helices (named A to R) followed
by a cytosolic carboxy-terminus that contains two conserved
cystathionine-ß-synthase (CBS) domains in eukaryotic CLCs
(Bateman, 1997) (Figure 1B). Each subunit binds anions with-
out any contribution from the other subunits—in full agreement
with two separate active centers that transport anions indepen-
dently in the two neighboring subunits. This peculiar architecture
had already been suggested based on early single channel record-
ings that demonstrated two equally spaced conductance states
and suggested the existence of two ion conduction pathways,
the so-called protopores, per individual CLC channel (Miller,
1982; Miller and White, 1984). Three separate chloride binding
sites within each subunit were identified in the three-dimensional
structures, Sint, Scen, and Sext, named after their position relative
to the extra- or intra-cellular side of the plasma membrane. The
central position forms a significant part of the selectivity filter
with the conserved amino acids S107, I109, F357, and Y445 in
addition to the less well conserved F348 and I356 (Figure 1C; all
positions given for EcClC) coordinating the chloride ion within
the conduction pathway (Dutzler et al., 2002, 2003; Lobet and
Dutzler, 2006). There are no full positive charges such as from
arginine or lysine side chains involved in the formation of anion
binding sites, in agreement with the notion that CLC proteins use
helical dipole moments to generate a positive electrostatic poten-
tial necessary for anion selectivity (Dutzler et al., 2002; Gouaux
and MacKinnon, 2005).
The separate CLC transporter structures show a similar back-
bone fold, but appear to represent different conformations of
the Cl−/H+ exchange cycle. Comparison of these conformations
reveals movements of a conserved glutamate side chain, E148
in EcClC (Figure 1C), from inside to outside of the conduction
pathway switching from Scen to Sext. Such movements depend
on the protonation status and likely account for the transport of
protons in a 2 Cl− to 1 H+ stoichiometry (Dutzler et al., 2003;
Accardi and Miller, 2004; Feng et al., 2010; Picollo et al., 2012).
The two carboxy-terminal CBS domains of eukaryotic CLC
channels are known to interact and form intra-molecular dimeric
complexes. Partial removal of CBS domains can cause either
loss-of-function, or alterations in channel gating or subcellular
distribution (Maduke et al., 1998; Estévez et al., 2004; Hebeisen
et al., 2004; Hebeisen and Fahlke, 2005; Garcia-Olivares et al.,
2008). A recent structure of a eukaryotic CLC transporter sug-
gested interactions between CBS domains and the intracellular
poles of helices D and R. Since these helices contain the serine
and tyrosine side chains coordinating Scen (S107 and Y445 in
EcClC) this interaction provides a structural basis for the regu-
lation of CLC function by clarboxy-terminal domains (Hebeisen
and Fahlke, 2005; Feng et al., 2010). Additional inter-subunit
interactions of CBS dimers was observed in vitro for isolated
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ClC-5 and ClC-Kb carboxy-termini (Meyer et al., 2007; Martinez
and Maduke, 2008). Such interactions might play a role in inter-
subunit communication and might contribute to cooperative
gating processes (Bykova et al., 2006).
FUNCTIONAL PROPERTIES OF CLC CHANNELS IN VOLTAGE CLAMP
EXPERIMENTS
Heterologous expression of CLC channels in Xenopus oocytes
and mammalian cells allowed detailed functional analysis of all
human CLC channels. Figure 2 shows whole-cell patch-clamp
recordings fromHEK293 cells over-expressing human CLC chan-
nels and illustrates the functional diversity of these distinct
proteins. For all recordings, cells were subject to a nearly symmet-
rical distribution of chloride across the plasma membrane, held
at 0mV and voltage steps over a broad range were applied.
Whereas ClC-Ka/barttin and ClC-Kb/barttin current
amplitudes are almost time-independent, voltage steps result
in time- and voltage-dependent relaxations of the ClC-1 and
ClC-2 current amplitude that can be used for the kinetic
analysis of channel gating. Changes in macroscopic current
amplitude usually follow the sum of two exponential functions
with separate time constants. The two activation and deacti-
vation time constants are due to the existence of two gating
mechanisms that either act on separate protopores or jointly
on both protopore (Miller, 1982). In all mammalian CLC
channels protopore gating is about 10-fold faster than common
gating (Miller, 1982; Saviane et al., 1999; Fischer et al., 2010;
Stölting et al., 2013) which led to the synonymous use of the
terms fast/protopore gate and slow/common gate. For many
channels these kinetic differences were used to separate the two
processes in macroscopic current recordings. The instantaneous
current amplitude at a tail pulse of fixed voltage translates into
the relative open probability of the channel at the end of the
preceding test voltage (Hodgkin and Huxley, 1952). Inserting
a short test pulse to a voltage at which the two gating processes
differ sufficiently in speed only manipulates the fast gate and thus
effectively fixes it at the same open probability for all preceding
voltage steps. Such an approach allows for measurements of
the voltage dependence of the slow gating process in isolation.
On the assumption that the fast and slow gating processes
are independent, the open probability of the fast gate can be
calculated as the ratio of the total open probability of the
channel to the percentage of open slow gates (Accardi and Pusch,
2000).
The skeletal muscle chloride channel ClC-1 (Figure 2A) is
open at 0mV, with fast and slow gates that are both activated by
membrane depolarization (Accardi and Pusch, 2000). Plotting the
current amplitude vs. the membrane potential reveals an inwardly
rectifying conductance (Fahlke et al., 1995). The ubiquitously
expressed ClC-2 is closed at positive potentials and activates
on a very slow time course upon membrane hyperpolarization
(Figure 2B) (De Santiago et al., 2005). ClC-2 gating is again char-
acterized by two kinetically different gating processes that are
both activated by hyperpolarization rather than by depolariza-
tion as in ClC-1. Both ClC-1 and ClC-2 display strongly inward
rectifying macroscopic current amplitudes, but with a different
mechanistic basis. Inward rectification of ClC-1 channels is due
to voltage-dependent unitary conductances that decrease at posi-
tive voltages to approximately 10% of the conductance at negative
potentials (Pusch et al., 1994; Fahlke et al., 1995; Rychkov et al.,
1998; Stölting et al., 2014). In contrast, ClC-2 unitary current
conductances are voltage-independent, and rectification of ClC-
2 currents is due to voltage-dependent gating that closes the fast
gate at voltages positive to 0mV (Stölting et al., 2013).
ClC-Ka (Figure 2C) and ClC-Kb (Figure 2D) can only be
functionally expressed together with the accessory subunit bart-
tin (Estévez et al., 2001; Waldegger et al., 2002; Scholl et al.,
2006; Fischer et al., 2010). In mammalian cells, ClC-Kb/barttin
currents are time-independent with slight bidirectional rectifi-
cation. In contrast, ClC-Ka/barttin channels close very rapidly
upon steps to voltages negative to −100mV. These very fast pro-
cesses likely correspond to fast protopore gating in these channels
(Riazuddin et al., 2009; Fischer et al., 2010). When expressed
in oocytes, ClC-Ka/barttin and ClC-Kb/barttin display dramat-
ically different gating properties (Imbrici et al., 2014). Whereas
absolute open probabilities of ClC-Ka/barttin are close to 1 in
mammalian cells (Riazuddin et al., 2009), corresponding val-
ues are very small in Xenopus oocytes (Gradogna et al., 2010).
Moreover, ClC-K channels expressed in mammalian cells often
respond to pharmacological modification in a different way than
channels expressed in Xenopus oocytes (Imbrici et al., 2014). The
reason for these functional differences is not yet clear. There
might be yet unknown interaction partners of ClC-K/barttin that
are present in one expression system, but not in the other one.
Alternatively, the functional properties of ClC-K/barttin channels
might depend on the lipid composition. Although expression in
mammalian cells appear to be more similar to renal cells than
amphibian oocytes it is not possible to judge at themoment which
of the two distinct biophysical and pharmacological phenotypes
is closer to the functional properties of native channels.
Chloride is by far the most abundant anion in vivo thus also
leading to the designation of CLC channels as “chloride” instead
of “anion” channels. One must note that the selectivity filter of
CLC channels does not perfectly distinguish between different
kinds of anions seen as a permeability for other (unphysiological)
anions such as I−, F−, SCN−, NO−3 , or Br−. However, studies
using the other abundant physiological anion, HCO−3 , are rare.
A significant permeability for bicarbonate was found in studies of
ClC-5 inXenopus laevis oocytes (Mo et al., 1999) and amathemat-
ical study of epithelial ion fluxes in the ascending limb of Henle
predicts that a significant bicarbonate conductance of ClC-Kb is
necessary for proper renal function (Weinstein, 2010).
DOUBLE BARRELED CLC CHANNELS EXHIBIT UNIQUE SINGLE
CHANNEL PROPERTIES
Single channel recordings now exist for the majority of human
CLC channels (Figures 3A–D) (Saviane et al., 1999; Fischer et al.,
2010; Weinberger et al., 2012; Stölting et al., 2013). When ana-
lyzing recordings from membrane patches that contain only one
CLC channel the amplitude histogram plot therefore shows a
total of three peaks, corresponding to the closed channel, or
to the opening of either one or two protopores (right side of
Figures 3A–D). This property results from the unique dimeric
architecture of CLC channels with two ion conduction pathways.
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FIGURE 2 | Whole-cell patch clamp recordings demonstrate the
functional variability of human CLC channels. (A–D) Representative
whole-cell current responses from HEK293T cells expressing ClC-1,
ClC-2, ClC-Ka/barttin, or ClC-Kb/barttin to the indicated voltage protocols
(left column). Right column shows the voltage dependences of the
open probabilities of fast protopore (filled circles) and slow common
gates (open circles) as well as of the probability of the channel to be
conductive (thick line). The ClC-1 recording is reproduced from
Weinberger et al. (2012) while ClC-Ka and −Kb recordings were
reproduced from Riazuddin et al. (2009).
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FIGURE 3 | Single channel recordings or noise analysis of whole cell
recordings provide properties of individual CLC channels. (A–D)
Representative single channel recordings from homodimeric ClC-1,
homodimeric ClC-2, heteroconcatameric ClC-1-ClC-2 as well as ClC-Ka
co-expressed with barttin. All recordings from homodimeric channels show
two separate open states representing one or two simultaneously open
protopores. ClC-Ka/barttin exhibits a high open probability approaching 1 so
few deviations from the fully opened state are seen. (A–C) were
reproduced and modified from Stölting et al. (2014) and (D) from Riazuddin
et al. (2009). (E) Representative plot of the mean current and variance of
HEK293T cells expressing the human ClC-1 channel with cysteine 277
exchanged to tyrosine. Voltage protocol (top), mean current (middle), and
variance (bottom) are obtained at pH 5.9 to increase the open probability
of channels containing this particular mutant. (F) Plotting variance against
the mean current does not result in a simple parabolic distribution. As
expected for double barreled channels with distinct protopore and
cooperative gating all data points fall in between the theoretical prediction
for channels with permanently open common gate (denoted as “i”) or
permanently open protopore gate (denoted as “2i”). The transition from
one parabola (dashed line) to the other one (line) indicates the slow
transition of the fast gate from closed to open over the recording time.
(G) Linear transformation of the plot in (F) facilitates the identification of
the changes to fast gate open probability. (E–G) were reproduced and
modified from Weinberger et al. (2012).
Single channel recordings from the prototypic ClC-0 revealed
long periods with closed channels that were interrupted by phases
in which both protopores rapidly switch between open and closed
states. During these burst-like phases, the distribution of the
probabilities of encountering any of the three amplitude levels is
determined almost exclusively by the fast protopore gate whereas
the long closed durations are based on the slow common gate.
Since individual gating of protopores is independent of the neigh-
boring subunit, the times spent in each of the three current
levels is binomially distributed and this behavior has been termed
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“binomial bursts” (Miller, 1982). ClC-1 and ClC-2 exhibit gating
processes that resemble the behavior of ClC-0, with fast protopore
gating and slow cooperative processes (Figures 3A,B) (Saviane
et al., 1999; Accardi and Pusch, 2000; Zúñiga et al., 2004). Barttin
appears to lock the cooperative gate in an open conformation,
so that single channel recordings of ClC-Ka/barttin channels
exclusively show an even number of independently gated pro-
topores (Fischer et al., 2010). No single channel recordings in
heterologous expression systems have been reported so far for
ClC-Kb.
The analysis of heterodimeric channels consisting of one ClC-1
and one ClC-2 subunit provided novel insights into the molec-
ular basis of slow cooperative gating (Stölting et al., 2014).
Such hetero-dimeric channels lack cooperative gating but retain
two separate fast and slow gating mechanisms for each proto-
pore. In ClC-1-ClC-2 hetero-dimers, fast protopore gating of
ClC-1 resembles corresponding processes in ClC-1 homodimers.
However, the ClC-1 protopore is kept closed at positive poten-
tials by a novel slow gate that permits only transient openings
in the hetero-dimeric assembly. In contrast, the ClC-2 protopore
is active at all potentials and is under control of fast and slow
gating processes that are kinetically different from those identi-
fied for the ClC-1 protopore. In single channel recordings, this
behavior resulted in only one conductance state corresponding
to the ClC-2 protopore (Figure 3C). These results suggest that
common gating of CLC channels ultimately arises from confor-
mational changes within an individual protopore (Bennetts and
Parker, 2013; Stölting et al., 2014). Homo-dimerization permits
the synchronization of these processes and common gating. In
hetero-dimers this coordination is impaired so that slow gating
steps are not cooperative anymore.
Single channel amplitudes for the ClC-2 protopore were sig-
nificantly smaller in hetero-concatamers than in ClC-2 homo-
dimers (Figure 3C). Taking together, these experiments demon-
strate how closely the two subunits cooperate within one
individual channel. Gating and permeation through every trans-
port protein is governed by electrostatic interactions between
charged side chains or helical dipole moments. One could imag-
ine that changes in the orientation of defined side chains or of
helices via inter-subunit interactions might adjust the electro-
static field of the adjacent CLC subunit and thus cooperatively
determine gating and permeation.
Noise analysis is an alternative technique for determining the
properties of individual channels (Sigworth, 1980). It is particu-
larly useful for channels with small unitary current amplitude and
has often helped correlating unitary and macroscopic currents of
certain ion channels. Such analysis is based on the assumption
that the underlying gating processes are stochastic events and that
small deviations in macroscopic current amplitude are caused by
fluctuations in the number of open channels. Whereas current
noise generated by channels with only one conductance levels is
easy to analyze, the double-barreled architecture of CLC channels
requires modifications of such noise analysis (Fischer et al., 2010;
Weinberger et al., 2012).
Voltage steps cause a relaxation of the open probability of
voltage-dependent channels from the previous equilibrium value
to the new one and result in time-dependent changes of the
current amplitude. During these current relaxations the single
channel current amplitude is constant whereas the number of
open channels changes. Repetitive sampling of current responses
to the same voltage step (Figure 3E) permits determination of the
mean current over all recorded voltage steps and mean variances
for multiple time points after the voltage step. For channels with
only one conductance state a plot of the current variance (σ2) vs.
the mean amplitude<I> (Figure 3F) yields a parabolic distribu-
tion that depends on the: single channel amplitude (i) and the
number of channels (N).
σ2 = i 〈I〉 −
( 〈I〉2
N
)
or after linearization by dividing the variance by current
σ2
〈I〉 = i −
〈I〉
N
Some CLC channels show a significant deviation from this the-
ory, which is even clearer after linearization of the parabolic plot
(Figures 3F,G). The basis for this peculiar current-variance rela-
tionship is the double-barreled architecture of these channels.
Taking two protopores with two structurally and kinetically dis-
tinct gating processes permits a satisfactory quantification of this
behavior. The macroscopic current of the CLC channels is given
by the product of the open probability of each gate, the number
of channels and twice the single protopore amplitude:
I = N · 2i · Pp(t) · Pc(t)
The current variance depends on the number of channels (N),
the single protopore amplitude (i) and the time-dependent open
probabilities for the fast protopore gate (Pp(t)) and the slow
common gate (Pc(t)):
σ2 = N · 2i2 · Pp(t) · Pc(t) ·
(
1 − 2Pp (t) · Pc (t)+ Pp (t)
)
These equations can be simplified to:
σ2 = (1 + Pp(t)) · i 〈I〉 −
( 〈I〉2
N
)
demonstrating that this quantitative treatment permits the single
channel amplitude to be determined if one of the two open prob-
abilities is known. Even if the variance-current plot does not show
obvious deviations from a parabolic shape, the dependence of the
initial slope on the minimum open probability of the protopore
gate (Pp) has to be taken into account.
In all cases current variances must fall in between two extremes
that are given by:
σ2 = 2i · 〈I〉 −
( 〈I〉2
N
)
for Pp(t) = 1
σ2 = i · 〈I〉 −
( 〈I〉2
2N
)
for Pc(t) = 1
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Using such an analysis we demonstrated that a myotonia-causing
mutation, C277Y, results in a significant decrease of the slow gate
open probability (Weinberger et al., 2012). Assuming a maximal
value of twice the lowest determined variance/current ratio, these
results also demonstrated diminished single channel amplitudes
as compared to wild type ClC-1 from single channel recordings.
This finding is rather unexpected since C277 does not contribute
to the formation of the conduction pathway in the known three-
dimensional structures. It provides additional support for the
notion of a tight interaction of subunits in determining the gating
and permeation properties of CLC channels.
MOLECULAR DETERMINANTS OF CLC CHANNEL FUNCTION
In the past 20 years the combination of site-directed mutagenesis
and functional analysis of mutant channels has provided insights
into mechanisms and sequence determinants of CLC channel gat-
ing and anion permeation. Site-directedmutagenesis experiments
on several CLC channels demonstrated that the same conserved
glutamate at the beginning of the F helix whose movement is
necessary for proton transport in CLC antiporters is important
for fast gating in ClC-0, ClC-1, and ClC-2 (Fahlke et al., 1997;
Dutzler et al., 2003; Niemeyer et al., 2003; De Santiago et al., 2005)
and was therefore named “gating glutamate.” In ClC-K channels
this “gating glutamate” is replaced by valine, and ClC-Ka and
ClC-Kb are therefore often assumed to lack protopore gating.
However, single channel recordings from ClC-Ka/barttin revealed
short gating events and a very high open probability of the chan-
nel (Riazuddin et al., 2009; Fischer et al., 2010). The time spent
in the open and closed states was found to be binomially dis-
tributed and the highest observed conductance level was always
a multiple of two demonstrating the observed opening and clos-
ing transitions are caused by individual protopore gating without
interference by the permanently open common gate (Riazuddin
et al., 2009; Fischer et al., 2010). The homologous rat ClC-K1 is
also functional in the absence of barttin and thus provides the
opportunity to study the effects of barttin on ClC-K function in
more detail. In the absence of barttin, rClC-K1 displays protopore
and common gating processes with opposite voltage dependence.
Co-expression with barttin results in permanent opening of the
common gate, again as shown by the binomial distribution of
the amplitude histograms for each conductance state upon co-
expression with barttin (Fischer et al., 2010). Although the results
imply that side chains separate from the original “gating gluta-
mate”must be involved in protopore gating, the precisemolecular
basis of such gating has not yet been identified in ClC-K channels.
In ClC-0, ClC-1, and ClC-2 a cysteine close to the inter-
face domain and in close proximity to Sext (C212 in ClC-0,
C277 in ClC-1 or C258 in ClC-2) is critically involved in slow
cooperative gating (Lin et al., 1999; Accardi et al., 2001; Zúñiga
et al., 2004; De Santiago et al., 2005; Weinberger et al., 2012).
Again, ClC-K channels lack a cysteine at this position suggest-
ing that this side chain is not required for common gating. Based
on the three-dimensional structures of CLC antiporters, it was
recently proposed that slow cooperative gating of ClC-0 and ClC-
1 depends on the tyrosine residue that coordinates the central
chloride binding site (Bennetts and Parker, 2013). This tyrosine
is believed to interact with the gating glutamate as the final step
of slow gating to occlude or open the pore. How the common
gate is simultaneously conferred to both protopores is, however,
still unknown. It is not even known if the antiporters within the
CLC family are even under control of a cooperative gating mech-
anism. Based on previous studies it seems reasonable, however,
that rearrangements of the carboxy-terminus might be required
for cooperative gating (Bykova et al., 2006; Garcia-Olivares et al.,
2008; Ma et al., 2011; Stölting et al., 2013).
CONVERSION OF CLC ANTIPORTERS INTO CHANNELS/UNIPORTER
To understand the structural features that distinguish CLC anion
channel and anion-proton exchanger attempts were undergone
to convert CLC antiporters into anion channels or vice versa.
However, these attempts have not been fully successful so far. The
substitution of a glutamate residue (“gating glutamate” E148 in
EcClC) within the F helix by alanine abolishes secondary-active
transport and permits passive anion permeation (Accardi and
Miller, 2004; Jayaram et al., 2008). The corresponding exchange
also abolished the coupling of proton transport to chloride flux
in the human anion/proton antiporters ClC-4 and ClC-5 (Picollo
and Pusch, 2005; Scheel et al., 2005). Another glutamate residue
in EcClC (E203) could also be neutralized by substitution with an
alanine to impair the coupling of chloride and proton transport
resulting in a switch toward a channel-like phenotype possibly
due to a lack of the internal binding site for protons (Accardi et al.,
2005). Some exchanges of the central tyrosine (Y445 in EcClC)
also resulted in an apparent channel phenotype with a strong
decrease of the observed anion density for Scen in accompany-
ing X-ray crystal structures (Accardi et al., 2006). Mutating E148
together with Y445 increased unitary anion transport in EcClC
above values observed for uniporters, however, the observed
conduction rates were well below corresponding values in CLC
channels (Jayaram et al., 2008). It should be noted, however, that
all of these residues are mostly conserved even across the chan-
nel branch of the CLC family thus providing important insight
into the conduction process of anions and protons but failing to
demonstrate the actual difference between transporters and chan-
nels from the same family. There are no reports of a CLC channel
being converted into an antiporter so far.
CELLULAR PHYSIOLOGY AND PATHOPHYSIOLOGY OF CLC
CHANNELS
CLC-1
Adult skeletal muscle is unique among excitable tissues in its
high resting chloride conductance. It exceeds the sarcolemmal
potassium conductance by a factor of more than four and is
so high that changes in the extracellular chloride concentra-
tions do not modify the resting potential, but rather results in
changes of the intracellular [Cl−] until the equilibrium poten-
tial of chloride ions again equals the muscle resting potential
(Hodgkin and Horowicz, 1959; Bretag, 1987). The physiolog-
ical role of ClC-1 became clear by studying the pathophysi-
ology of myotonia congenita, a rare human condition that is
characterized by muscle stiffness upon sudden forceful move-
ments (Bryant and Morales-Aguilera, 1971; Adrian and Bryant,
1974). In myotonic muscle fibers, the membrane potential does
not completely repolarize after a series of action potentials
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during voluntary contractions, resulting in the so-called after-
depolarization. After-depolarizations can result in prolonged
electrical activity of the muscle fibers even after the end of neu-
ronal activity and are thus the electrophysiological basis to muscle
stiffness (Adrian and Bryant, 1974). The time course of the
action potential itself is unchanged in muscle fibers from the
myotonic goat indicating that ClC-1 does not contribute to the
repolarization of the action potential itself (Bryant, 1973).
The after-depolarization of myotonic muscle fibers is due
to the accumulation of K+ within the t-tubules that occurs in
normal as well as in myotonic muscle during repetitive action
potentials. In normal skeletal muscle, high resting chloride con-
ductance reduces the sarcolemmal length constant and prevents
propagation of this depolarization along the sarcolemma. In the
absence of the shunting sarcolemmal chloride conductance in
myotonic muscle, the t-tubular depolarization leads to depolar-
ization of the sarcolemmal membrane causing sustained activity
of the muscle fiber. It is still under debate whether ClC-1mediates
its shunting conductance only through channels localized along
the outer sarcolemmal membrane or along the t-tubules as well. A
recent study presented evidence for a homogeneous distribution
across t-tubules and the sarcolemmal membrane (DiFranco et al.,
2011) while another paper described an exclusive expression in
the surface membrane (Lueck et al., 2010). Regardless of the exact
localization, muscle chloride channels allow skeletal muscle fibers
to electrically tolerate t-tubular membrane invaginations and the
subsequent potassium accumulation (Figures 4A–C).
ClC-1 was cloned from skeletal muscle as the first mam-
malian member of the CLC family (Steinmeyer et al., 1991).
Mutations in CLCN1 as the genetic basis of myotonia congenita
proved that ClC-1 indeed represents the adult skeletal muscle
chloride channel (Koch et al., 1992; George et al., 1993). ClC-1
exhibits an inwardly rectifying unitary current conductance at
symmetrical chloride concentrations with a value of approxi-
mately 1.5 pS below −85mV and a 10-fold lower conductance at
voltages positive to the chloride reversal potential (Pusch et al.,
1994; Stölting et al., 2014). ClC-1 exhibits an open probability of
0.38 at −85mV (Weinberger et al., 2012) and only opens mini-
mally during the upstroke of the action potential, which is faster
than the ClC-1 activation time course (Fahlke and Rüdel, 1995;
Accardi and Pusch, 2000; Hebeisen and Fahlke, 2005). These spe-
cific anion conduction and gating properties make ClC-1 ideally
suited for providing a large resting chloride conductance with
only minimum interference with the action potential. These fea-
tures minimize Na+ influx during the action potential and thus
reduce ATP consumption following sustained muscular activity
that is required for active Na+ extrusion via the Na+/K+-ATPase.
Although voltage-dependent gating of ClC-1 is not strictly
necessary for its physiological function, almost all disease-causing
mutations that have been studied perturb channel gating [with
the notable exception of G230E that affects ion permeation and
selectivity of ClC-1 (Fahlke et al., 1997)]. The first myotonia
mutation that was functionally analyzed, D136G (Figure 4D),
couples channel opening to the intracellular chloride concentra-
tion and thus inverts the voltage dependence of ClC-1 (Fahlke
et al., 1995). D136G hClC-1 only opens at voltages below the
chloride equilibrium potential. Chloride efflux at such voltages
will reduce the intracellular chloride concentration until reaching
a chloride reversal potential similar to the sarcolemmal resting
potential. At these [Cl−] D136G hClC-1 will be permanently
closed, in full agreement with low resting chloride conductance
and hyperexcitability. D136G hClC-1 resembles ClC-2 in many
properties and thus illustrates the importance of isoform-specific
specialization within the CLC family. Subsequently, several muta-
tions were identified that shifted the activation curve of ClC-1
to more depolarized potentials (Pusch et al., 1995; Rhodes et al.,
1999; Wu et al., 2002) (Figure 4D). Such shifts decrease the open
probability of hClC-1 at −85mV and thus decrease resting chlo-
ride conductance. A similar change in channel gating is the basis
of myotonia in the goat (Beck et al., 1996). Other mutations result
in changes of gating so that the two gating processes develop an
opposing pattern of voltage-dependence, one stimulated bymem-
brane depolarization and the other by hyperpolarization as in
T550M ClC-1 channels (Warnstedt et al., 2002; Wu et al., 2002;
Weinberger et al., 2012). In the last two decades a large variety
of disease-causing mutations have been found in patients with
myotonia congenita. These mutations are spread over the whole
coding region of ClC-1, and their functional analysis has pro-
vided many important insights into sequence determinants of
CLC channel function (Fahlke et al., 1995, 1997; Wollnik et al.,
1997; Saviane et al., 1999; Richman et al., 2012; Weinberger et al.,
2012; Lee et al., 2013).
Recently, a novel ClC-1 variant was identified by exomic
sequencing in patients suffering from idiopathic epilepsy (Chen
et al., 2013). This study also showed ClC-1 mRNA transcripts and
protein bands stained with antibodies against ClC-1 in parts of
the human brain. This novel role and localization of ClC-1 might
lead to new perspectives for the physiology of CLC channels in the
central nervous system. However, the absence of central neurolog-
ical symptoms in patients with myotonia congenita or in animal
models of this disease raises the question of how functional
changes in ClC-1 might contribute to epilepsy.
CLC-2
ClC-2 was discovered shortly after ClC-1 in excitable as well as
in non-excitable cells (Thiemann et al., 1992). ClC-2 exhibits
a voltage-independent single channel conductance of only ∼2.4
pS per protopore (Stölting et al., 2013). It is closed at posi-
tive potentials and activates over a very slow time course upon
hyperpolarization. After activation at negative potentials, volt-
age steps back to positive potentials result in a very slow current
deactivation. Whereas the protopore gate closes completely at
positive potentials the slow common gate exhibits a minimum
open probability well above zero (De Santiago et al., 2005; Garcia-
Olivares et al., 2008). Similar gating features have been observed
in Xenopus oocytes and in mammalian cells, however, activa-
tion and deactivation kinetics were significantly slower in oocytes.
The kinetics of gating is modified by nucleotide binding to the
carboxy-terminus (Dhani et al., 2008; Stölting et al., 2013) and by
the surrounding lipid composition (Hinzpeter et al., 2007). It was
also found that the activation and deactivation gating of ClC-2 is
significantly accelerated by deletions or modifications of carboxy-
or amino-terminal domains suggesting the involvement of large
rearrangements of these protein domains (Garcia-Olivares et al.,
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FIGURE 4 | ClC-1 is the major muscle chloride channel. (A) In
skeletal muscle, the resting membrane potential is determined by the
potassium gradient across the sarcolemmal and t-tubular membrane.
Action potentials results in the opening of L-type calcium channels
(DHPR) that in turn open intracellular channels (RyR) releasing calcium
from the sarcoplasmic reticulum needed for the contraction of the
muscle. (B) A train of action potentials results in the displacement of
potassium through channels to the extracellular side. As the diffusion of
ions from the t-tubules is slow, potassium accumulates and causes
transient changes of the potassium reversal potential which are,
however, offset by the high sarcolemmal chloride conductance. (C) In
muscle fibers expressing dysfunctional ClC-1 channels, t-tubular
depolarization is propagated to the surface membrane and can trigger
spontaneous generation of new action potentials even after the end of
the voluntary movement. This “after-depolarization” is marked in red.
(D) Representative recordings from mutant ClC-1 channels carrying
disease-causing mutations illustrating the diverse results of single amino
acid exchanges on ClC-1 gating.
2008; Saint-Martin et al., 2009; Stölting et al., 2013) such as
reported for ClC-0 and ClC-1 (Bykova et al., 2006; Ma et al.,
2011).
Gating of ClC-2 depends on intracellular [Cl−] so that channel
opening only occurs at potentials negative to the Cl− equilibrium
potential (Niemeyer et al., 2004). In cells in which the membrane
potential is clamped by channels of different selectivity to more
negative potentials it might be assumed that ClC-2 will stay open
and permit anion efflux until the chloride equilibrium potential
equals the membrane potential. ClC-2 could therefore contribute
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to the regulation of intracellular anion concentrations in neurons,
glia, or to the efflux of chloride in epithelial cells. Early studies
on ClC-2 heterologously expressed in Xenopus oocytes revealed
activation by osmotic gradients, suggesting that ClC-2 might be
involved in cellular osmotic homeostasis (Gründer et al., 1992).
However, functional properties of ClC-2 are clearly different
from volume-activated anion channels (Nilius et al., 1997), and
cells lacking ClC-2 exhibit unchanged volume-activated anion
currents (Nehrke et al., 2002).
ClC-2 can assemble with accessory subunits that are not
required for the function of ClC-2, but rather determine the sub-
cellular localization and modify channel gating in different cell
types. The first reported accessory subunit of ClC-2 was the pro-
tein cereblon which binds to the carboxy-terminus of ClC-2 and
putatively regulates the expression of functional channels in the
retina (Hohberger and Enz, 2009). More recently, a novel sub-
unit called GlialCAM (synonymous with the earlier designation
HepaCAM) has been shown to associate with ClC-2 (Jeworutzki
et al., 2012). GlialCAM is a protein of 416 amino acids in length
with one transmembrane domain and a large Ig-like V- and C2-
type amino terminal domain. In heterologous expression systems,
co-expression of GlialCAM with ClC-2 switched the phenotype
toward an almost constitutively open channel. While GlialCAM
is only interacting with ClC-2 in vivo due to its cell specific
expression, it was found to associate with multiple CLC chan-
nels in vitro, such as ClC-0, ClC-1, and ClC-K/barttin affecting
localization and common gating parameters (Jeworutzki et al.,
2014).
ClC-2 currents recorded from brain slices from GlialCAM
knock-out animals are not dramatically different from corre-
sponding traces obtained from WT animals, suggesting that
GlialCAMdoes not exert the same dramatic effect on channel gat-
ing in native cells as in heterologous expression system (Hoegg-
Beiler et al., 2014). Work on MLC1 knock-out mice furthermore
suggested that MLC1, a membrane protein of unknown function
associated to megalencephalic leukoencephalopathy (Leegwater
et al., 2001), might stabilize GlialCAM in the plasma mem-
brane and thus act as an additional binding partner within the
ClC-2/GlialCAM complex (Hoegg-Beiler et al., 2014).
Among the best understood roles of ClC-2 is the chloride
efflux at the basolateral membrane in the gastro-intestinal tract,
facilitating NaCl and subsequently H2O reabsorption (Figure 5A)
(Catalán et al., 2002, 2004). A putative activator of ClC-2, lubipro-
stone, ameliorates chronic idiopathic constipation, probably by
stimulating the secretion of chloride and water into the colon
lumen. The success of this treatment is in agreement with a role
of ClC-2 also in apical chloride secretion (Cuppoletti et al., 2004).
During development, ClC-2 is highly expressed in lung tissue
and has been proposed as a potential pathway to replace the
missing chloride conductance in patients suffering from cystic
fibrosis (Schwiebert et al., 1998, −2). However, Clcn2−/− mice
do not suffer from lung disease, and additional ClC-2 knock-
out in CFTR−/− mice did not deteriorate the phenotype of cystic
fibrosis these animals (Zdebik et al., 2004). Studies of knock-out
mice also revealed a testicular degeneration and retinal degenera-
tion, underlining the roles of ClC-2 in retinal pigment epithelia
and in Sertoli cells where this channel might be involved in
regulating the highly specialized fluid secretion of these tissues
(Bösl et al., 2001). Although not linked to any renal disease,
ClC-2 was also early on shown to be expressed in the kid-
ney (Thiemann et al., 1992). An analysis of mRNA transcripts
revealed a significant expression in all nephron segments except
for the cortical collecting duct and the outer medullary collect-
ing duct and was found to be modulated by aldosterone in rats
(Ornellas et al., 2002). ClC-2 was also shown to be expressed
in skeletal muscle (Thiemann et al., 1992). However, ClC-2 cur-
rents could neither be recorded from kidneys nor skeletal muscle.
It is conceivable that ClC-2 might form heterodimers in these
tissues where the other CLC channels such as ClC-1 (Lorenz
et al., 1996; Stölting et al., 2014) or the ClC-K channels are
expressed.
ClC-2 is expressed in neuronal and glial cells (Staley, 1994;
Nobile et al., 2000; Sìk et al., 2000), but its role in the central
nervous system is still not sufficiently understood. Mutations in
CLCN2 were found in human patients with idiopathic general-
ized epilepsy as well as in leukoencephalopathy (D’Agostino et al.,
2004; Kleefuß-Lie et al., 2009; Saint-Martin et al., 2009; Klassen
et al., 2011; Depienne et al., 2013; Stölting et al., 2013). CLCN2
loss-of-function mutations result in myelin vacuolation in the
brain and spinal cord and in mild neurological deficits such as
cerebellar ataxia (Depienne et al., 2013). The lack of ClC-2 cause
similar pathological changes in human patients as observed in
Clcn2−/− mice. Similar changes in brain morphology are caused
by the loss of GlialCam andMLC1, most likely because these pro-
teins assemble into a protein complex that prevents the formation
of such vacuoles.
Clcn2−/− mice display abnormal cortical activity and a higher
susceptibility to induced seizures, but do not show overt signs
of epileptic seizures animals (Blanz et al., 2007; Cortez et al.,
2010). Changes in the dynamic regulation of intraneuronal chlo-
ride concentrations might be the basis of this hyperexcitability
(Blanz et al., 2007; Földy et al., 2010). Activation of GABAA recep-
tors hyperpolarizes neurons via a transient chloride influx. ClC-2
might be activated by the resulting increases in intracellular [Cl−]
and provide an exit pathway for chloride ions (Figure 5B). This
mechanism was first demonstrated in experiments in which ClC-
2 was expressed in dorsal root ganglion cells. This maneuver
reduced [Cl−]int and inverted depolarizing into hyperpolarizing
GABA currents (Staley et al., 1996). Another possible mechanism
postulates that ClC-2 channels might remain opened at positive
voltages and permit a repolarizing influx of chloride (Ratté and
Prescott, 2011).
Several CLCN2 missense mutations found in patients suffer-
ing from idiopathic epilepsies change ClC-2 gating in a similar
fashion (Figures 5C,D), i.e., faster activation and deactivation
time courses. This uniform functional consequence supports
the notion that these changes in channel gating might con-
tribute to the pathogenesis of epilepsy. In mutant ClC-2, efflux
of chloride after repetitive GABA stimulation will activate more
rapidly and thus conduct a depolarizing current with more rapid
onset than WT channels. A causal role of CLCN2 mutations has
been questioned in the past by several authors (Niemeyer et al.,
2010; Depienne et al., 2013; Jentsch, 2013). One argument was
that these mutations are not linked to epilepsy in a Mendelian
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FIGURE 5 | ClC-2 is expressed in epithelia as well as excitable cells. (A) In
colonic enterocytes chloride is absorbed from the luminal side via a
chloride/bicarbonate exchanger and then transported through basolateral
ClC-2 to the interstitium. Sodium follows through a luminal channel or
sodium/proton exchanger and is transported to the interstitium via the
Na+/K+ ATPase (Catalán et al., 2002). (B) The role of ClC-2 in excitable cells
such as neurons is still under debate. A probable mechanism leaves ClC-2
closed at the potassium equivalent resting membrane potential but changes
in the chloride reversal potential through Cl− influx open ClC-2 and permit
chloride efflux through this channel. Chloride efflux possibly causes
membrane depolarization and hyperexcitability. (C) Single channel recordings
from mutant ClC-2 channels with mutations found in patients with idiopathic
epilepsies. These mutations shorten the long closed states caused by
closures of the common gate. (D) A plot of the probability finding the ClC-2
channel in the closed state for the indicated duration demonstrates the
disease-associated changes of common. (E) W570X—that was recently
found in patients with idiopathic generalized epilepsy—causes similar
acceleration of ClC-2 activation and deactivation as the previously studied
mutant H573X when expressed in HEK293 cells. (F) H573X partially opens
the slow gate of ClC-2. (C,D) were reproduced and modified from Stölting
et al. (2013). The data from H573X ClC-2 was reproduced and modified from
Garcia-Olivares et al. (2008).
fashion. Some of these sequence variations display incomplete co-
segregation and occur not only in affected, but also in unaffected
individuals of the same family. However, such inheritance pat-
tern is not uncommon in idiopathic generalized epilepsy. There
is increasing evidence that this disease is not simply due to the
occurrence of single disease-causing mutations, but rather results
from the co-existence of multiple sequence variations affecting
distinct genes (Klassen et al., 2011). The manifestation and the
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severity of the disease depend on the combined functional con-
sequences of multiple coincident genetic risk factors favoring
hyperexcitability in the central nervous system. A polygenic het-
erogeneity model suggests that CLCN2mutations affect neuronal
excitability but that these changes only result in epilepsy together
with mutations in other genes (Klassen et al., 2011).
One of the mutations linked to idiopathic epilepsy, W570X,
was also identified in a genome sequencing study of leukoen-
cephalopathy patients (Depienne et al., 2013). This mutation
is very similar to a truncation of ClC-2 studied earlier in our
laboratory and causes a strong acceleration of gating activation
and inactivation with an almost constitutively open slow gate
(Figures 5E,F) (Garcia-Olivares et al., 2008). However, the patient
suffering from leukoencephalopathy did not show seizures, puta-
tively due to almost complete degradation of the truncated
mutant channel (Depienne et al., 2013).
CLC-Ka/CLC-Kb
ClC-Ka and ClC-Kb are exclusively expressed in the nephron and
in the stria vascularis of the inner ear (Figures 6A,B). The phys-
iological role of these proteins was clarified by the generation of
the Clcnk1−/− mouse (ClC-K1 is the rodent homolog of ClC-Ka)
with pronounced diabetes insipidus and the linkage ofCLCNKB to
Bartter syndrome, a human condition characterized by impaired
renal urine concentration resulting in hypotension with elevated
renin and aldosterone levels (Simon et al., 1997; Matsumura et al.,
1999). These findings suggested that ClC-Ka and ClC-Kb are
crucial for normal urinary concentration.
Initial attempts to characterize the function of these channels
failed (Kieferle et al., 1994) since ClC-Ka and Kb can only be
functionally expressed together with the accessory subunit bart-
tin (Estévez et al., 2001; Waldegger et al., 2002; Scholl et al.,
2006). Barttin was cloned as the gene product of the disease
gene of Bartter syndrome type 4 that combines the pronounced
renal symptoms of other Bartter syndromes with sensorineu-
ral deafness (Birkenhäger et al., 2001). It is a 320 amino acid
protein that contains two putative transmembrane domains fol-
lowed by a long carboxy terminus. Truncations of barttin after
position 72 left the function of ClC-K/barttin channels in het-
erologous expression systems almost unaffected (Scholl et al.,
2006; Janssen et al., 2009). The interaction of Barttin with the
ClC-K channels is proposed to be along the two transmem-
brane helices B and J, but further details about the interaction
of channel and accessory subunit are still lacking (Figure 6C)
(Tajima et al., 2007).
In mice and rats, ClC-K1, ClC-K2, and barttin are both dis-
tributed starting from the thin over the thick ascending duct of
Henle’s loop well into to the collecting duct (Vandewalle et al.,
1997; Waldegger et al., 2002; Nissant et al., 2004). The two ClC-K
isoforms, however, show differences in their expression along
different parts of the nephron so that channels consisting of ClC-
Ka and barttin are now thought to mediate the passage of Cl−
through the epithelium predominantly in the thin ascending limb
while ClC-Kb/barttin is believed to be necessary for the reup-
take of chloride in the thick ascending limb and sustaining the
transepithelial potential that results in paracellular absorption of
diverse cations including Ca2+ andMg2+. ClC-K and barttin also
exhibit abundant expression in the stria vascularis of the inner ear.
ClC-K/barttin channels permit the basolateral efflux of Cl− ions
accumulated by the NKCC1 Na+-K+-Cl− co-transporter which
is necessary for the generation of the endocochlear potential.
Neither expression of ClC-Ka nor of ClC-Kb results in
visible currents when the barttin subunit is lacking. Barttin
exerts multiple functions on ClC-K channels. It supports the
exit from the endoplasmic reticulum, stimulates insertion into
and impairs removal of ClC-Ks from the surface membrane
(Figure 6D) (Scholl et al., 2006). Moreover, barttin increases the
ClC-K protein stability by stimulation of complex glycosylation
(Figures 6E,F) (Hayama et al., 2003; Scholl et al., 2006; Janssen
et al., 2009). ClC-Ka and ClC-Kb are not functional without
the accessory subunit and are switched into a conducting state
by association with barttin. Upon co-expression, ClC-Ka and
ClC-Kb show time-independent, mostly non-rectifying currents
(Janssen et al., 2009; Fischer et al., 2010). ClC-Ka/barttin chan-
nels are permanently open at voltages positive to −150mV. The
decay of the open probability at voltages negative to −150mV
results in a characteristic “hook” in macroscopic current-voltage
plots. The single channel conductance of ClC-Ka is approximately
30 pS and thus significantly larger than for other CLC channels
(Figure 3). So far, unitary properties of ClC-Kb have not been
determined.
Several CLCNKB missense mutations have been found in
patients with Bartter syndrome (Simon et al., 1997; Fukuyama
et al., 2004). These mutations usually cause loss-of-channel func-
tion and are thus expected to reduce water reabsorption by
affecting the cortico-medullary osmotic gradient. There is one
report about a patient with combined mutations in CLCNKA
and CLCNKB. As expected the patient suffers from severe renal
salt wasting and sensorineural deafness which closely mim-
icked mutations in the BSND gene that also affect both chlo-
ride channels simultaneously (Schlingmann et al., 2004). One
mutation—predicting T481S ClC-Kb—was found in a genetic
screen of hypertensive cohorts. In heterologous expression sys-
tems it permits ClC-Kb channel opening even in the absence
of barttin (Jeck et al., 2004; Sile et al., 2009). The mutation
might increase salt and subsequently water reabsorption and
thereby increase systemic blood pressure. Moreover, increasing
chloride currents in the stria vascularis will augment the endo-
cochlear potential and thereby lower the hearing threshold (Frey
et al., 2006). Since reduced blood volume through increased
water excretion may enhance renin secretion and upregulate the
renin-angiotensin-aldosterone system (RAAS), loss-of-function
of ClC-K/barttin channels might increase the risk of heart fail-
ure. Recently, a CLCNKA variant predicting R83G ClC-Ka was
reported to result in loss-of-function of this channel and was
suggested as risk factor for heart failure (Cappola et al., 2011).
Other naturally occurring variants of ClC-Ka that increase sys-
temic blood pressure following an increased NaCl load were
linked to chronic, salt-dependent hypertension (Barlassina et al.,
2007).
The important role of ClC-K/barttin channels in the regula-
tion of the body’s salt and water content makes these channels
an important target for pharmacological intervention (Picollo
et al., 2004; Liantonio et al., 2006, 2012; Imbrici et al., 2014).
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FIGURE 6 | ClC-K channels are necessary for transepithelial solute
transport in the loop of Henle and the stria vascularis of the inner ear.
(A) Expression of ClC-Ka/barttin and ClC-Kb/barttin in the thin ascending and
thick ascending limb of the loop of Henle. Chloride is absorbed on the luminal
side either by a secondary-active transport mechanism or diffusion through
apical channels and then conducted through ClC-Ka/barttin or ClC-Kb/barttin
to the interstitial side. ClC-Ka/barttin is necessary for the passive reabsorption
of NaCl in the thin ascending limb. In the thick ascending limb, ClC-Kb/barttin
supports the basolateral chloride efflux that is necessary for the electrogenic
NaCl absorption. The absorption of NaCl establishes a transepithelial
potential that additionally drives the paracellular flux of Mg2+ or Ca2+.
(B) ClC-Ka/barttin and ClC-Kb/barttin mediate basolateral chloride efflux and
support charging the endolymph via K+ secretion within the stria vascularis.
(C) Barttin is thought to bind to the B (magenta) and J (blue) helix of ClC-K
channels (Tajima et al., 2007). (D) Confocal fluorescence images (kindly
provided by Dr. Daniel Wojciechowski) of YFP-ClC-Ka alone show a
predominant staining of intracellular membranes (left side). Upon
co-expression of CFP-barttin, ClC-Ka is relocalized to the plasma membrane
(right side). (E) Barttin switches ClC-Ka and ClC-Kb into an active state as
seen in a normalized current vs. voltage plot. (F) Barttin increases complex
glycosylation (#) and the stability of the ClC-K/barttin complex in the plasma
membrane. (A,B) are modified after Fahlke and Fischer (2010).
ClC-K/barttin activators might correct loss-of-function of chan-
nels carrying naturally occurring mutations associated with
Bartter syndrome or idiopathic deafness. ClC-K/barttin channel
blockers might serve as diuretics or as anti-hypertensive drugs.
However, there are potential side effects that should be carefully
investigated. Hearing appears to be much more sensitive to ClC-
K channel activity (Riazuddin et al., 2009) than kidney function.
Although the blood-labyrinth barrier shields the inner ear epithe-
lia from the general circulation (Juhn and Rybak, 1981), several
compounds such as salicylate, furosemide or aminoglycoside
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antibiotics readily affect inner ear function. Furthermore, a long
term follow-up of patients suffering from Bartter syndrome
showed persistent hyperreninemia, secondary hyperaldostero-
nism and development of proteinuria in many patients even if
other symptoms are rather well controlled (Bettinelli et al., 2007).
Possible side effects of pharmacological alterations in ClC-K func-
tion therefore have to be carefully tested and might even preclude
a widespread clinical use.
Missense mutations that prevent barttin expression result in
a very severe renal phenotype (Janssen et al., 2009; Fahlke and
Fischer, 2010; Nomura et al., 2011) often with endstage renal fail-
ure in young adulthood. Since other BSND mutations that also
abolish formation of functional ClC-K/barttin do preserve renal
function it is tempting to speculate whether these channels exert
additional functions in renal cells. Successful treatment of these
rare cases might require a better understanding of the interac-
tion of ClC-K with the subunit barttin. However, at present, it
is not clear how barttin interacts with ClC-K channels, and it is
also unclear whether this interaction can be targeted to modify
channel function.
OUTLOOK
Anion channels exist in all cells of the human body and fulfill
multiple physiological functions. The importance of these chan-
nels is highlighted by genetic variants associated tomajor diseases.
Evolution has resulted in multiple anion transport protein fam-
ilies, with very different functions and physiological roles. The
CLC family is currently the largest known gene family encoding
anion channels and transporters, and many aspects of CLC chan-
nel function are already well understood. CLC channel function
has been studied using whole-cell and single channel patch clamp
recordings and fluorescence imaging. Three-dimensional struc-
tures from related proteins have provided detailed insights into
the molecular architecture of these proteins. Using knock-out and
knock-in animal models we can study the consequences of CLC
functions on cellular processes.
CLC channels are functionally very different from voltage-
gated cation channels, and many of these special properties are
due to their evolution from transporters. Many secondary-active
transporters can assume channel-like slippage modes (DeFelice
and Goswami, 2007). However, the CLC family has undergone
a rather strict separation between these modes into antiporters
and channels without transporter activity. The molecular deter-
minants of this differentiation are not clear. Whereas the replace-
ment of a single amino acid (D136G) can convert one channel,
ClC-1, into a channel with properties very similar to ClC-2,
it has not yet been possible to transform a CLC channel into
a CLC transporter. CLC channels have attracted a great deal
of attention because of their unique double-barreled structure.
We still do not understand the molecular functions and the
physiological impact of this curious design. How do the two
subunits communicate with each other, and what is the phys-
iological advantage of having two more or less synchronized
pores?
The newly predicted localization of ClC-1 in the central ner-
vous system raises questions concerning potential roles of this
channel in this organ system. It is still unclear how ClC-2 prevents
neurodegeneration and which role mutant ClC-2 plays in cen-
tral nervous hyperexcitability. ClC-Ka and -Kb are important
pharmacological targets, however, no compound targeting these
channels has yet entered clinical practice. The possible formation
of hetero-dimeric CLC channels with properties greatly different
from homo-dimeric channels also warrants further investigation.
Although much knowledge exists about the chloride conductance
of CLC channels, it might be worthwhile to study the perme-
ation of bicarbonate as well. We also lack a thorough molecular
understanding of the way accessory subunits such as barttin or
GlialCAMmodify CLC channels.
Studying the CLC family has always been driven by both, the
curiosity about the biophysical properties and their physiological
relevance. The last 25 years have provided the knowledge and the
tools to address many of the remaining questions. This work will
hopefully lead to a detailed understanding of the molecular phys-
iology and pathophysiology of these channels and may improve
the quality of life of many patients with rare or common diseases.
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